Medical Research Future Fund consultation for the development of the Australian Medical Research and Innovation Strategy and related Priorities
Overview
This phase of the consultation process is now closed.
The Australian Medical Research Advisory Board held its first meeting at Parliament House on 4 May 2016. Under the Medical Research Future Fund Act 2015, the Advisory Board is tasked with determining the Australian Medical Research and Innovation Strategy (Strategy) and related Priorities. The Strategy is determined every five years and the Priorities every two years.
Members of the Advisory Board want to work with the community to shape the Strategy and identify the Priorities for the Medical Research Future Fund.
Your opinions are essential to ensure an appropriate focus for the Medical Research Future Fund Strategy, and the initial round of Priorities. The Advisory Board is keen to hear views and ideas from those who deliver, use or stand to benefit from health services and health and medical research.
The Advisory Board will be accepting written submissions from 6 May 2016 until 6 June 2016. There will be no extensions beyond the closing date. Submissions on the Strategy and Priorities can be made by using the pro formas found below under the "Related Documents" heading and then emailing to MRFF@health.gov.au.
Please read the Call for Submissions before preparing your submission.
IMPORTANT: Each submission must not be longer than three pages (a pro forma is available to use) and use minimum size 11 font.
Audiences
- Aboriginal and Torres Strait Islander People
- Seniors
- Men
- Women
- Carers and guardians
- Families
- Parents
- Young people
- Non-government organisations
- State government agencies
- Commonwealth agencies
- Local governments
- Health professionals
- Health workforce
- General public
- Community groups
- Businesses
- Contracted Service Providers
- BPRU staff
- Graduates
- Online and Publications staff
- Secretariat
- PCCD
- Health staff
- HPRG (TGA) Staff
- Prescription medicines
- Complementary medicines
- Over-the-counter medicines
- Medical Devices & IVDs
- Biogicals
- Other
Interests
- Hospitals
- e-Health
- Health technology
- Medicare
- Legislation
- Pharmaceutical benefits
- Health insurance
- Rural health services
- Women's health
- Children's health
- Learning and development
- Alcohol
- Tobacco
- Chronic disease
- Communicable diseases
- Mental health
- Drugs and substance abuse
- Food standards
- Organ and tissue donation
- Immunisation
- Hearing
- Aboriginal and Torres Strait Islander health
- Environmental health
- Prescription drugs
- Preventative health
- Dental health
- Information Technology
- Strategic Policy
- Policy Development
Share
Share on Twitter Share on Facebook